Juan Pablo Duque (JP)
Juan Pablo Duque (JP) is a junior analyst, supporting the execution team on every step of the M&A process. Prior to joining, he worked as a summer analyst intern in J.P. Morgan’s Corporate Investment Bank Risk Division, where he analyzed company exposure and helped ensure that the firm was well capitalized. Through that experience, JP gained a foundation in financial analysis, modeling, and data manipulation. He is at the University of Miami with a double major in Finance and Economics, and is the founder of a College of Business organization, TargetCanes, focused on the mentorship and professional advancement of students seeking to pursue a career in banking.
In 1982, Mr. Blair founded IEG Venture Management, an entrepreneurial venture capital firm located in Chicago that specializes in technology-based startups in the Midwest. While managing IEG, Mr. Blair worked as the President and CEO, and later as the Chairman and CEO of Pride-Tech. Previously, Mr. Blair worked for the Environmental Protection Agency as their Chief of Staff for the Deputy Administration. He also served as the Assistant to James Schlesinger, Secretary of the Department. Thereafter, Mr. Blair worked at the Heizer Corporation as their Treasurer and Vice President of Business Development for energy, environmental and aerospace/defense deals. Mr. Blair received a BA in Political Science and Economics from Yale University and an MPA in Decision Analysis from Harvard University, Kennedy School of Government.
Stanley B. Blaylock
Mr. Blaylock brings over two decades of healthcare and financial experience to his position as president and CEO of Physicians Immediate Care, where he manages all operations of the company and leads the firm’s growth strategy. Before joining Physicians Immediate Care, Mr. Blaylock was president of Walgreens Health Services, the managed care and specialty services division of the nation’s largest drugstore chain. Prior to that, he was president and CEO of Medmark, a leading national provider of specialty pharmacy services that he co-founded in 2003, and sold to Walgreens in 2006. Mr. Blaylock has also held executive positions for Deutsche Bank (as its global co-head of health care investment banking), Option Care, Inc., and Citibank’s corporate banking division. In addition to serving on the Board of Directors of Physicians Immediate Care, Mr. Blaylock also serves on the boards of NovaSom, Inc., AxelaCare Holdings, Inc. and SoloHealth, Inc. Mr. Blaylock received a bachelors degree in economics and communication studies from the University of Virginia, and an MBA from Harvard Business School.
Joel B. Braunstein, MD
Dr. Braunstein is a board-certified cardiologist and internist, and co-founder of LifeTech Research, established for the purpose of providing technical and market due-diligence research services to institutional investors and emerging companies. Dr. Braunstein has played a key operational role in the start-up of numerous life sciences companies, and currently sits on five corporate boards. Dr. Braunstein received his MD with highest distinction from Northwestern University Medical School in 1996. Additionally, he completed an MBA in 2004 and maintained a cardiology faculty position at Johns Hopkins University. In addition to his various management responsibilities, Dr. Braunstein currently maintains an Adjunct Assistant Professorship at the Yale Center for Outcomes Research and Evaluation (CORE) and the Yale School of Medicine.
Mr. Buxton is the President and founder of BTB Associates LLC, a healthcare strategy and management consulting company. In this role, he has been actively working with both hospital systems and health plans to develop strategies and operational plans to better manage risk, while improving efficiencies and quality. Mr. Buxton has over 30 years of experience in the health care and health plan management sectors, including health plan operations, marketing, sales, government programs, external relations and mergers & acquisitions. Previously, Mr. Buxton served as Senior Vice President for HCSC and before that, Senior Vice President for Anthem Blue Cross Blue Shield (Ohio, Indiana and Kentucky). Mr. Buxton earned a BA from Brown University and a Master of Public Health/Hospital Administration degree from Yale University.
Martin Z. Craig
Mr. Craig has over three decades of healthcare and financial experience, which he brings to his current position as CEO of HBG Health Ventures, an equity advisory firm that equips early stage and mature healthcare companies with capital and grounded business guidance. Mr. Craig was the Founder and Executive VP of HHL Financial Services, a national healthcare firm providing revenue cycle management services. HHL Financial Services was the largest healthcare revenue cycle management company at the time of its sale to the Hillman family. Mr. Craig also served as CEO of Argent Healthcare, a GTCR portfolio company. He grew this platform into a national healthcare service company through the acquisition, merger and integration of several RCM companies, concluding in the sale of the business to Roundtable Healthcare Partners. Throughout his career, Mr. Craig built and advised successful healthcare companies by relying on highly skilled staff members, developing best practices, and providing outstanding execution for his clients. Martin is a graduate with a B.A. degree from the University of Illinois and holds a J.D. from the John Marshall Law School.
Mr. Dickman has over 35 years of experience in healthcare, and most recently served as President & CEO of QuadMed, LLC, an onsite primary care provider located in Milwaukee, WI. Prior to QuadMed, Mr. Dickman served as the President & CEO of Prime Therapeutics, a pharmacy benefit management company providing services to 16 million commercial members and 1 million Medicare members. Previously, Mr. Dickman worked at Tillinghast-Towers Perrin as a Pharmacy Leader. Mr. Dickman also worked as a senior executive at Travelers and other managed health companies. Mr. Dickman earned his BS in Pharmacy from Purdue University and his MBA from the University of Chicago. He has served on the boards of the PCMA, the American Associates of PPOs, and the American Managed Health Care Association.
Mr. Duthie has spent the last 25 years as a health care entrepreneur through his activities as a General Partner at Prince Ventures, a venture capital firm he co-founded. Prince Ventures specialized in early stage health care and life science firms, funding over 60 companies over the fund’s lifetime. Mr. Duthie’s area of focus is the health care services industry, including rehabilitation hospitals, occupational medicine, disease management, women’s health, hospice, managed care, alternative site psychiatric care and healthcare information technology. He frequently served on the boards of directors of its portfolio companies, including CorSolutions for example, and assisted with assembling management teams to deliver growth. CorSolutions is a leading participant in the disease management sector of the health management industry. Mr. Duthie had been a member of the Board of Directors since 1994, and became Chairman of the Board in early 2002. In August 2005, Mr. Duthie was named CEO and led the company through a sale in early 2006.
Mr. Guckes has more than 25 years of management experience leading healthcare and business service companies. He held various executive positions as Chairman, President & COO and EVP & COO of both public and private organizations, with revenues ranging from $100 million to $1 billion. Mr. Guckes is currently a Managing Partner at Patriarch Partners, leading their healthcare, staffing and business services division. Mr. Guckes began his career with Baxter International, followed by Owens & Minor, American Medical Response, Medical Staffing Network, and finally Omniflight before joining Patriarch Partners. Mr. Guckes has a broad management background, and has led teams through periods of dynamic industry change. He has extensive turnaround and restructuring experience targeted at rationalizing company operations and capital structures. Additionally, he has significant M&A and integration experience. Greg is a graduate of Northwestern University, with a BA in Economics.
Steven C. Straus
Mr. Straus' healthcare career has spanned over three decades in which he has served in several leadership roles in both supplier and provider sectors, ranging from start-ups to fortune 100 companies. Mr. Strauss recently partnered with Pharos Capital Group, LLC to serve as the CEO of Dermatology and MedSpa, Inc., a dermatology platform based in the Mid-Atlantic region. He has prior experience working in the dermatology space when he served as the CEO of American Laser Skincare, a provider of aesthetic services. In 2012, Mr. Straus joined Daniels International, a privately-held, Australian-based company as President, Strategic Development. He oversaw the development and implementation of the company's regulated medical waste services and product strategy for U.S. healthcare providers in acute and alternate care markets. Prior to joining Daniels, he served as CEO of LCA Vision/Lasik Plus, a publicly-traded provider of laser vision correction surgical services. He has served in a number of leadership roles in healthcare-related businesses throughout his professional career, including executive positions at MSO medical, TLC vision, Jordan Industries, and Columbia/HCA/Medical Care America. Mr. Straus began his career at American Hospital Supply Corporation and Baxter Healthcare.
Dr. Weiss is a board-certified dermatologist and founder of Tegalux Biosciences, a biopharmaceutical incubator focused on accelerating early to mid-stage biopharmaceutical compounds addressing unmet needs in dermatology. Dr. Weiss was the Senior Medical Director at Connetics Corporation, through its acquisition by Stiefel / Glaxo-SmithKline. During his tenure, he successfully advanced three drug candidates through FDA approval. Dr. Weiss graduated with his BA in Philosophy from Yale University, his MD and MHSc from the Duke University School of Medicine, and his MBA from the J.L. Kellogg School of Management. Additionally, he completed his residency in Dermatology at Stanford University Medical Center and a fellowship in bioethics at the National Institutes of Health.
In addition to his management responsibilities, Dr. Weiss maintains an adjunct faculty position at the University of Miami Miller School of Medicine/Jackson Health System in the Department of Dermatology and is a member of the Executive Advisory Board (EAB) of the Academy for Creativity & Leadership (ACL) in the Department of Health Management & Informatics at the University of Central Florida.